Utero-relaxant effect of PDE4-selective inhibitor alone and in simultaneous administration with β2-mimetic on oxytocin-induced contractions in pregnant myometrium

Journal of Obstetrics and Gynaecology Research

Volumn 35, Issue 1, 2009, Pages 20-25

  Franova, Sona ^a   Janicek, Frantisek ^b   Visnovsky, Jozef ^b   Dokus, Karol ^b   Zubor, Pavol ^b   Sutovska, Martina ^a   Nosalova, Gabriela ^a  

^a University Teaching Hospital in Martin   (Slovakia)

^b Martinska Fakultna Nemocnica   (Slovakia)

Author keywords

PDE 4 inhibitors; Pregnant myometrium; Uterine contractility

Indexed keywords

OXYTOCIN; ROLIPRAM; SALBUTAMOL;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; MYOMETRIUM; PREGNANT WOMAN; UTERUS CONTRACTION; UTERUS RELAXATION;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; DRUG SYNERGISM; FEMALE; HUMANS; MYOMETRIUM; OXYTOCIN; PHOSPHODIESTERASE INHIBITORS; PREGNANCY; ROLIPRAM; UTERINE CONTRACTION;

EID: 58849101397     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2008.00839.x     Document Type: Article

References (21)

1. Riemer RK, Heymann MA. Regulation of uterine smooth muscle function during gestation. Pediatr Res 1998 44 : 615 627.
2. Fuchs AR, Fields MJ, Freidman S, Shemesh M, Ivell R. Oxytocin and the timing of parturition. Influence of oxytocin receptor gene expression, oxytocin secretion, and oxytocin induced prostaglandin F2 alpha and E2 release. Adv Exp Med Biol 1995 395 : 405 420.
3. Summers RJ, Kompa A, Roberts S. Beta-adrenoreceptor subtypes and their desensitization mechanisms. J Auton Pharmacol 1997 17 : 331 343.
4. Silver PJ, Krafte DS. Pharmacology regulation of smooth muscle by ion channels, kinases, and cyclic nucleotides. In : Barany M (ed.). Biochem of Smooth Muscle Contraction. San Diego, CA : Academic Press, 1996 367 376.
5. Giembycz MA. Phosphodiesterase 4 and tolerance to beta 2-adrenoceptor agonists in asthma. Trends Pharmacol Sci 1996 17 : 331 336.
6. Goureau O, Tanfin Z, Harbon S. Prostaglandins and muscarinic agonists induce cyclic AMP attenuation by two distinct mechanisms in the pregnant-rat myometrium. Interaction between cyclic AMP and Ca2+ signals. Biochem J 1990 271 : 667 673.
7. Oger S, Méhats C, Barnette M, Ferré F, Cabrol D, Leroy MJ. Anti-inflamatory and uterorelaxant effects in human myometrium of new generation phosphodiesterase 4 inhibitors. Biol Reprod 2004 70 : 458 464.
8. Burnouf C, Pruniaux MP. Recent advances in PDE4 inhibitors as immunoregulators and anti-inflammatory drugs. Curr Pharm Des 2002 8 : 1255 1296.
9. Houslay MD, Adams DR. PDE4 cAMP phosphodiesterases: Modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem J 2003 370 : 1 18.
10. Méhats C, Tanguy G, Dallot E et al. Selective up regulation of phosphodiesterase-4 cyclic adenosine 3′,5′-monophosphate (cAMP)-specific phosphodiesterase variants by elevated cAMP content in human myometrial cells in culture. Endocrinology 1999 140 : 3228 3237.
11. Méhats C, Oger S, Leroy M. Cyclic nucleotide phosphodiesterase-4 inhibitors: A promising therapeutic approach to premature birth? Eur J Obstet Gynecol Reprod Biol 2004 117 : S15 S17.
12. Méhats C, Tanguy G, Paris B et al. Pregnancy induces a modulation of the cAMP phosphodiesterase 4-conformers ratio in human myometrium: Consequences for the utero-relaxant effect of PDE4-selective inhibitors. J Pharmacol Exp Ther 2000 292 : 817 823.
13. Schmitz T, Souil E, Hervé R et al. PDE4 inhibition prevents preterm delivery induced by an intrauterine inflammation. J Immunol 2007 178 : 1115 1121.
14. Méhats C, Tanguy G, Dallot E, Cabrol D, Ferré F, Leroy MJ. Is up-regulation of phosphodiesterase 4 activity by PGE2 involved in the desensitization of beta-mimetics in late pregnancy human myometrium? J Clin Endocrinol Metab 2001 86 : 5358 5365.
15. Ku CY, Qian A, Wen Y, Sanborn BM. Oxytocin stimulates myometria guanosine triphosphatase and phospholipase-C activities via coupling to Gaq/11. Endocrinology 1995 136 : 1509 1515.
16. Bhalla RC, Sanborn BM, Korenman SG. Hormonal interactions in the uterus: Inhibition of isoproterenol-induced accumulation of adenosine cyclic monophosphate by oxytocin and prostaglandins. Proc Natl Acad Sci USA 1972 69 : 3761 3764.
17. Schrey MP, Read AM, Steer PJ. Oxytocin and vasopressin stimulate inositol phosphate production in human gestational myometrial and decidual cells. Biosci Rep 1986 7 : 613 619.
18. Lindeman KS, Hirshman CA, Kuhl JS, Levitsky HI, Emala CW. Chronic oxytocin pretreatment inhibits adenylyl cyclase activity in cultured rat myometrial cells. Biol Reprod 1998 59 : 1108 1115.
19. Sanborn BM. Hormones and calcium: Mechanisms controlling uterine smooth muscle contractile activity. Exp Physiol 2001 86 : 223 237.
20. Méhats C, Tanguy G, Dallot E, Cabrol D, Ferré F, Leroy MJ. Is up-regulation of phosphodiesterase 4 activity by PGE2 involved in the desensitization of beta-mimetics in late pregnancy human myometrium? J Clin Endocrinol Metab 2001 86 : 5358 5365.
21. Torphy TJ, Zhou JL, Foley JJ, Sarau HM, Manning CD, Barnette MS. Salbutamol up regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2. Implications for the therapeutic use of beta-adrenoreceptor agonists. J Biol Chem 1995 270 : 23598 23604.